How can heart failure advocates in Spain seize current opportunities to improve care?

News & Events

22 September 2022


This year, Spain has become one of the few countries in Europe with a national strategy on cardiovascular health that prioritises heart failure among other conditions. But how heart failure can advocates fully seize this and other key opportunities to ensure national recommendations and targets for heart failure care are implemented at the local level?

Our latest policy brief attempts to answer this question, examining existing opportunities and mechanisms to advocate for guideline-recommended care in Spain.  This includes securing regional funding from organisations driving digital transformation, or calling on regional technology assessment agencies collecting heart failure data to provide policy recommendations.

This briefing is the first in our new series, From guidelines to action: opportunities for heart failure advocacy, which aims to equip advocates with a targeted analysis of the opportunities available in their countries and specific actions to take forward. These actions were developed based on successful examples from a number of health advocacy areas and interviews with national heart failure experts. Upcoming reports will focus on France, Germany and Italy.

Download the report


More from News & Events

HFPN launches European Heart Failure Mission infographic
HFPN launches European Heart Failure Mission infographic...
29 August 2023
The HFPN have launched an infographic as part of their European Heart Failure Mission to show that investment in optimal heart failure care is an investment in a sustainable and re...
Read article
Mental health in heart failure put under the spotlight in ne
Mental health in heart failure put under the spotlight in ne...
20 July 2023
The HFPN published a new call to action to raise awareness of the relationship between heart failure and mental health, and drive change for this issue at EU level....
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .